GlassScriptPhysician profile
David James Smits
NPI 1639597354
$2,392.99
in general payments reported to CMS, 2019-2025
19 companies · $591 in 2025
The $591 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $94.69 · 2021: $54.26 · 2022: $434 · 2023: $566 · 2024: $391 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,547.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $606.60 | 2022-2025 | Xen Glaucoma Treatment System, Durysta |
| Regeneron Healthcare Solutions, INC. | $323.29 | 2019-2024 | Eylea, Eylea Hd |
| New World Medical,INC. | $303.83 | 2022-2024 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Allergan, INC. | $235.08 | 2019-2022 | |
| Alcon Vision LLC | $204.50 | 2020-2025 | Rocklatan, Clareon, Clareon Panoptix Pro |
| Glaukos Corporation | $150.14 | 2019-2025 | Idosetr, Gts100-Glaukos Istent Trabecular Micro-Bypass Stent System |
| Tarsus Pharmaceuticals, INC. | $111.56 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $95.94 | 2025 | Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $77.16 | 2022-2025 | Cequa |
| Oyster Point Pharma, INC. | $54.97 | 2023-2025 | Tyrvaya |
| Apellis Pharmaceuticals, INC. | $52.44 | 2023 | Syfovre |
| Novartis Pharmaceuticals Corporation | $35.11 | 2022 | |
| Astellas Pharma US INC | $29.99 | 2025 | Izervay |
| Ocular Therapeutix, INC. | $26.77 | 2022-2024 | Dextenza |
| Thea Pharma INC. | $19.58 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Rayner Intraocular Lenses Limited | $17.98 | 2024 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Biotissue Holdings INC. | $16.45 | 2025 | |
| Lensar, INC. | $12.20 | 2025 | Lensar Laser System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Smits listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.